tauroursodeoxycholic acid (TUDCA)
PKUFH-MASLD-MILKHI-2026-01
Phase 2 small_molecule active
Quick answer
tauroursodeoxycholic acid (TUDCA) for Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active